An active pharmaceutical ingredient, or API, is the component of a medicine intended to provide its therapeutic activity.
API purity, physical properties and consistency can influence downstream processing, formulation performance and finished-product quality. Crystallization can help isolate and purify a target compound while influencing particle form and processability.
Aurorium manufactures selected active pharmaceutical ingredients, including potassium chloride, magnesium salicylate, niacin and zinc acetate. Crystallization capability, quality-focused operations and commercial manufacturing experience support dependable supply for appropriate applications.
Potential outcomes
Pharmaceutical buffers and process solutions are materials used to establish or adjust defined conditions such as pH, concentration and ionic strength during synthesis, purification and formulation.
Material concentration, purity and consistency can affect process performance, while packaging and delivery format can influence operational efficiency. These considerations become more significant as processes scale.
Aurorium supplies high-purity pharmaceutical buffers, sodium hydroxide, potassium hydroxide and USP/WFI water solutions used throughout formulation, synthesis, purification and manufacturing workflows. cGMP-capable manufacturing, formulation and packaging capabilities support customer requirements from development through commercial production.
Potential outcomes
Functional pharmaceutical excipients are non-active formulation components selected to provide a specific role in processing, stability, coating, delivery or dosage-form performance.
In oral solid dosage forms, excipients can support processing, stability, release characteristics and the physical performance of coatings. Plasticizers modify the flexibility and processability of polymer systems, helping support film formation and coating integrity.
Aurorium supplies citrate ester and sebacate ester plasticizers for pharmaceutical formulation and drug-delivery applications. The portfolio includes ATBC, ATEC, TBC, TEC and DBS, supported by esterification expertise and scalable manufacturing capabilities.
Potential outcomes
Small molecule API synthesis uses intermediates, precursors, catalysts, reagents and solvents to transform starting materials into the required active compound through controlled reaction and purification stages.
The suitability of these materials can affect reaction selectivity, conversion, impurity formation and purification demands. Process development must balance chemistry performance with safety, scalability, material availability, waste generation and manufacturing practicality.
Aurorium provides specialty intermediates, pharmaceutical precursors, catalysts, reagents and solvents used in small molecule synthesis and process chemistry. Relevant offerings include pyridine derivatives, DMAP, Vitride reducing agent and 2,6-lutidine, supported by hydrogenation, distillation and other manufacturing technologies.
Potential outcomes
Selected active ingredient for appropriate pharmaceutical applications.
View productActive pharmaceutical ingredient supported by quality-focused manufacturing.
View productSelected active ingredient for suitable pharmaceutical applications.
Request InfoSelected active ingredient manufactured for demanding quality requirements.
View productFunctional pharmaceutical excipients supporting coating and drug-delivery applications.
View PortfolioSpecialty plasticizers supporting flexible pharmaceutical polymer systems.
View PortfolioPellets and formulated solutions supporting pharmaceutical processing requirements.
View PortfolioPyridine derivatives, DMAP, Vitride and 2,6-lutidine for process chemistry.
Request InfoSmall molecule development can involve challenges around reaction performance, physical form, formulation functionality and commercial manufacturability.
Explore capabilities
Route and material choices can affect selectivity, impurities, purification and scale-up.
Aurorium applies specialty-chemistry expertise to intermediates, precursors, reagents and functional ingredients.
Excipients contribute to formulation performance rather than simply adding bulk.
Aurorium connects material properties with selected dosage-form and drug-delivery requirements.
Isolation conditions can influence purity, physical form and processability.
Aurorium uses crystallization expertise to support selected active ingredients and repeatable manufacturing.
Ester chemistry enables functional excipients such as citrate and sebacate plasticizers.
Aurorium combines esterification expertise with scalable production for formulation and coating applications.
Purity, functionality, handling and scale decisions can have downstream consequences.
Aurorium works with customers to align material and process requirements with production considerations.
Dependable access to active ingredients, functional excipients and pharmaceutical process solutions becomes increasingly important as programs approach commercial production.
Explore capabilities
Regulated applications require defined systems, documentation and consistent execution.
Aurorium offers cGMP-capable operations for suitable products and sites.
Selected synthesis routes require suitable equipment, controls and manufacturing experience.
Aurorium applies hydrogenation capability to appropriate intermediates and process-chemistry requirements.
Quality and consistency may depend on controlled purification and isolation.
Aurorium applies product- and site-specific distillation and crystallization capabilities.
Selected excipients and specialty materials depend on controlled polymer or ester chemistry.
Aurorium combines established process technologies with scalable production.
Requirements change from development quantities to commercial demand.
Aurorium supports scalable manufacturing, packaging options and continuity planning.
An API is intended to provide therapeutic activity. An excipient is a non-active formulation component selected to support processing, stability, delivery or dosage-form performance.
Plasticizers are used to modify the flexibility and processability of polymer systems, including selected pharmaceutical coating and drug-delivery applications.
Aurorium supports appropriate programs with selected active ingredients, functional excipients, synthesis materials, buffers, process solutions and scalable manufacturing capabilities.
